Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome


      An 8 year-old boy with Asperger's syndrome had difficulties in communicating with his teachers and classmates. He occasionally stole out of the classroom. He could not sleep at night recalling his awful experience and kept crying every night and refused to go to school. The treatment with fluvoxamine was started at the dose of 25 mg daily. Four weeks after the treatment, his repetitive behavior and hyperactivity decreased and night crying diminished. Although he still has difficulties in communicating with others, he is now able to attend extra-curricular classes in a private school. Fluvoxamine, a selective serotonin re-uptake inhibitor that has been mainly used for patients with depression and obsessive-compulsive disorder, might be effective for compulsive symptoms and sleep disturbance of patients with pervasive developmental disorders.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Godbout R.
        • Bergeron C.
        • Limoges E.
        • Stip E.
        • Mottron L.
        A laboratory study of sleep in Asperger's syndrome.
        NeuroReport. 2000; 11: 127-130
        • Howlin P.
        • Asgbarin A.
        Diagnosis of autism and Asperger's syndrome.
        Dev Med Child Neurol. 1999; 41: 834-839
        • Harvey R.J.
        • Cooray S.E.
        The effective treatment of severe repetitive behaviour with fluvoxamine in a 20 year old autistic female.
        Int Clin Psychoparmacol. 1995; 10: 201-203
        • McDougle C.J.
        • Naylor S.T.
        • Cohen D.J.
        • Vorkmar F.R.
        • Heninger G.R.
        • Price L.H.
        A double blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.
        Arch Gen Psychiat. 1996; 53: 1001-1008
        • McDougle C.J.
        • Price L.H.
        • Goodman W.K.
        Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder; A case report.
        J Autism Dev Disord. 1990; 20: 537-543
        • Cook E.H.
        • Rowlett R.
        • Jaselskis C.
        • Leventhal B.L.
        Fluoxetine treatment of children and adults with autistic disorder and mental retardation.
        J Am Acad Child Adolesc Psychiat. 1992; 31: 739-745
        • Hollander E.
        • Wong C.M.
        Obsessive-compulsive spectrum disorders.
        J Clin Psychiat. 1995; 56 (discussion 53–55): 3-6
        • Wilson S.J.
        • Bell C.
        • Coupland N.J.
        • Nutt D.J.
        Sleep changes during long-term treatment of depression with fluvoxamine a home based study.
        Psychopharmacology. 2000; 149: 360-365
        • Bahr C.
        • Ursing C.
        • Yasui N.
        • Tybring G.
        • Bertilsson L.
        • Rojdmark S.
        Fluvoxamine but not citalopram increases serum melatonin in healthy subjects an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
        Eur J Clin Pharmacol. 2000; 56: 123-127
        • Furusho J.
        • Kubagawa T.
        • Saitoh N.
        • Matsuzaki K.
        • Yamakawa H.
        • Iikura Y.
        The first Japanese pediatrics case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor.
        Pediatr Int. 2000; 42: 451-452